These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 234821)

  • 1. Enhancement of the antihypertensive effect of hydrochlorothiazide in dogs after suppression of renin release by beta-adrenergic blockade.
    Sweet CS; Mandradjieff M
    Clin Sci Mol Med; 1975 Feb; 48(2):147-51. PubMed ID: 234821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of timolol and hydrochlorothiazide on blood-pressure and plasma renin activity. Double-blind factorial trial.
    Chalmers J; Tiller D; Horvath J; Bune A
    Lancet; 1976 Aug; 2(7981):328-31. PubMed ID: 60566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative effects of timolol and hydrochlorothiazide on blood pressure, heart rate and plasma renin activity: results of a double-blind factorial trial in patients with essential hypertension.
    Chalmers JP; Horvath JS; Korner PI; Tiller DJ; Bune AJ; England JD; Fletcher PJ
    Clin Sci Mol Med Suppl; 1976 Dec; 3():517s-519s. PubMed ID: 799560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-blockade, renin and blood-pressure.
    Weber MA; Drayer JI; Laragh JH
    Lancet; 1977 Feb; 1(8007):367-8. PubMed ID: 64892
    [No Abstract]   [Full Text] [Related]  

  • 5. Attenuation of hydrochlorothiazide-induced hypokalemia in dogs by a beta-adrenergic blocking drug, timolol.
    Sweet CS; Gaul SL
    Eur J Pharmacol; 1975; 32(02):370-4. PubMed ID: 238860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bevantolol attenuates thiazide stimulated renin secretion and catecholamine release in diuretic resistant hypertensives.
    Fernandez PG; Snedden W; Vasdev S; Bolli P
    Can J Cardiol; 1989 Mar; 5(2):93-7. PubMed ID: 2565158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretics, beta-blockers or both as treatment for essential hypertension.
    Stumpe KO; Overlack O
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):189S-197S. PubMed ID: 37874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of essential hypertension using a new beta-receptor blockader (timolol maleate) combined with hydrochlorothiazide].
    Heinze A; Wessels F
    Verh Dtsch Ges Inn Med; 1974; 80():272-4. PubMed ID: 4156115
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Timolol, hydrochlorothiazide, blood-pressure, and renin in essential hypertension.
    Fyhrquist F; Kurppa K; Kannas M
    Lancet; 1976 Sep; 2(7987):691-2. PubMed ID: 60553
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigations on the antihypertensive activity of timolol and bendroflumethiazide and the combination in dogs and rats.
    Nielsen KC; Olsen UB; Ronne A; Arrigoni-Martelli E
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):500-12. PubMed ID: 990034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the mechanism of the synergistic antihypertensive activity of captopril and hydrochlorothiazide following acute administration in spontaneously hypertensive rats.
    Chan PS; Ronsberg MA; Cervoni P
    Clin Exp Hypertens A; 1982; 4(6):1019-34. PubMed ID: 7047003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of hydrochlorothiazide-induced elevations in plasma-renin activity by methyldopa in conscious renal-hypertensive dogs.
    Sweet CS; Wenger HC; O'Malley TA
    Can J Physiol Pharmacol; 1974 Oct; 52(5):1036-40. PubMed ID: 4425991
    [No Abstract]   [Full Text] [Related]  

  • 14. Aliskiren reduces blood pressure and suppresses plasma renin activity in combination with a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or an angiotensin receptor blocker.
    O'Brien E; Barton J; Nussberger J; Mulcahy D; Jensen C; Dicker P; Stanton A
    Hypertension; 2007 Feb; 49(2):276-84. PubMed ID: 17159081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified approach to the treatment of hypertension.
    Gillies A; Morgan T; Morgan G; Wilson M
    Med J Aust; 1977 Oct; 2(18):593-600. PubMed ID: 600190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on interaction of timolol, hydrochlorothiazide and amiloride in the rat.
    Scriabine A; Watson LS; Ludden CT; Russo HF; Bohidar NR
    Clin Exp Pharmacol Physiol; 1980; 7(2):209-13. PubMed ID: 7379349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of beta blockade in renal transplant recipients with or without host kidneys.
    Huysmans FT; van Heusden FH; Wetzels JF; Hoitsma AJ; Koene RA
    Transplantation; 1988 Aug; 46(2):234-7. PubMed ID: 2900564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medroxalol combined with hydrochlorothiazide in the treatment of hypertension.
    Vlachakis ND; Valasquez M; Alexander N; Maronde RF
    J Clin Pharmacol; 1983 Oct; 23(10):419-27. PubMed ID: 6139390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
    Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
    Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin II blockade during combined thiazide-beta-blocker treatment.
    Ibsen H; Leth A; McNair A; Christensen NJ; Giese J
    Scand J Clin Lab Invest; 1980 Jun; 40(4):325-31. PubMed ID: 6106282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.